Skip to content
Catalyst

coenzyme Q10Finding

Coenzyme Q10 decreases systolic blood pressure (setting unspecified)

lowersVery limited evidenceFindingreplicated ×1

01 · The sentence it was drawn from

“Treatment with coenzyme Q10 in subjects with systolic BP (SBP) > 140 mmHg or diastolic BP (DBP) > 90 mmHg resulted in mean decreases in SBP of 11 mmHg (95% CI 8, 14) and DBP of 7 mmHg (95% CI 5, 8).”
Quoted verbatim from Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.
This finding among the 88 findings on its endpoint

coenzyme Q10

Systolic blood pressure (setting unspecified)

lowers

Who
adults with primary hypertension (SBP >140 mmHg or DBP >90 mmHg); Cochrane meta-analysis of 3 RCTs, 96 participants, coenzyme Q10 versus placebo for at least 3 weeks
Dose studied
not reported

Very limited evidencePMID 19821418 · 2009

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

03 · The paper

The Cochrane database of systematic reviews
What else it reported2 findings · 1 compound · 2 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M38RFSY8FYHBCH0678D9JW49